Home
Home

Reckitt Benckiser

Reckitt Benckiser Repeats Growth Targets as Sales Rise on Flu

Reckitt Benckiser Repeats Growth Targets as Sales Rise on Flu
Bloomberg

China Biotech Week In Review: Regeneron Pharma, Bayer Start New Trial For DME Treatment

China Biotech Week In Review: Regeneron Pharma, Bayer Start New Trial For DME Treatment
Seeking Alpha

Reckitt in $482 mln deal to sell Bristol drugs in LatAm

Reckitt in $482 mln deal to sell Bristol drugs in LatAm
Reuters

Reckitt set to win Schiff as Bayer quits $1.4 bln fight

Reckitt set to win Schiff as Bayer quits $1.4 bln fight
Reuters

Reckitt trumps Bayer with $1.4 bln bid for Schiff

Reckitt trumps Bayer with $1.4 bln bid for Schiff
Reuters

Reckitt's Decision Opens The Door For Titan Pharma And BioDelivery Sciences

Reckitt's Decision Opens The Door For Titan Pharma And BioDelivery Sciences
Seeking Alpha
Submitted by moderatora on Wed, 10/13/2010 - 08:25

Device News

Titan's Implanted Addiction-Drug Device Works Better Than Placebo in Study
Bloomberg
»

News

Reckitt Benckiser buys back narcotic addition drug rights from Merck for $153 million
Yahoo/AP
»